Literature DB >> 8663084

Characterization of the denaturation and renaturation of human plasma vitronectin. I. Biophysical characterization of protein unfolding and multimerization.

P Zhuang1, M N Blackburn, C B Peterson.   

Abstract

Upon treatment with denaturing agents, vitronectin has been observed to exhibit conformational alterations which are similar to the structural changes detected when vitronectin binds the thrombin-antithrombin complex or associates with the terminal attack complex of complement. Denaturation and renaturation of vitronectin isolated from human plasma were characterized by changes in intrinsic fluorescence. Unfolding by chemical denaturants was irreversible and accompanied by self-association of the protein to form vitronectin multimers. Self-association was evaluated by equilibrium analytical ultracentrifugation which demonstrated that multimers form only during the refolding process after removal of denaturant, that multimeric vitronectin dissociates to constituent subunits readily upon treatment with chemical denaturant, and that intermolecular disulfide cross-linking occurs primarily at the dimer level among a subset of constituent vitronectin subunits within the multimer. The monomeric form of vitronectin isolated from human plasma partially unfolds at intermediate concentrations of denaturant to an altered conformation with a high propensity to associate into multimers. Folding of vitronectin in vivo appears to be regulated by partitioning of folding intermediates toward either of two conformations, one that exists as a stable monomer and another that associates into a multimeric form.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8663084     DOI: 10.1074/jbc.271.24.14323

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  Metals affect the structure and activity of human plasminogen activator inhibitor-1. I. Modulation of stability and protease inhibition.

Authors:  Lawrence C Thompson; Sumit Goswami; David S Ginsberg; Duane E Day; Ingrid M Verhamme; Cynthia B Peterson
Journal:  Protein Sci       Date:  2011-02       Impact factor: 6.725

2.  A mechanism for assembly of complexes of vitronectin and plasminogen activator inhibitor-1 from sedimentation velocity analysis.

Authors:  Kenneth H Minor; Christine R Schar; Grant E Blouse; Joseph D Shore; Daniel A Lawrence; Peter Schuck; Cynthia B Peterson
Journal:  J Biol Chem       Date:  2005-05-19       Impact factor: 5.157

3.  Activity of MMP-19 inhibits capillary-like formation due to processing of nidogen-1.

Authors:  B Titz; S Dietrich; T Sadowski; C Beck; A Petersen; R Sedlacek
Journal:  Cell Mol Life Sci       Date:  2004-07       Impact factor: 9.261

4.  Hysteresis as a Marker for Complex, Overlapping Landscapes in Proteins.

Authors:  Benjamin T Andrews; Dominique T Capraro; Joanna I Sulkowska; José N Onuchic; Patricia A Jennings
Journal:  J Phys Chem Lett       Date:  2012-12-18       Impact factor: 6.475

5.  New insights into heparin binding to vitronectin: studies with monoclonal antibodies.

Authors:  P Anne Underwood; Alan Kirkpatrick; Sue M Mitchell
Journal:  Biochem J       Date:  2002-07-01       Impact factor: 3.857

6.  Proteomic analysis of the serum in patients with idiopathic pulmonary arterial hypertension.

Authors:  Min Yu; Xing-xiang Wang; Fu-rong Zhang; Yun-peng Shang; Yu-xi Du; Hong-juan Chen; Jun-zhu Chen
Journal:  J Zhejiang Univ Sci B       Date:  2007-04       Impact factor: 3.066

7.  Prognostic utility of serum vitronectin levels in acute myocardial infarction.

Authors:  S Aslan; B Ikitimur; H A Cakmak; B Karadag; E Y Tufekcioglu; H Ekmekci; H Yuksel
Journal:  Herz       Date:  2014-05-15       Impact factor: 1.443

8.  Characterization of physicochemical properties of ivy nanoparticles for cosmetic application.

Authors:  Yujian Huang; Scott C Lenaghan; Lijin Xia; Jason N Burris; C Neal Stewart; Mingjun Zhang
Journal:  J Nanobiotechnology       Date:  2013-02-01       Impact factor: 10.435

9.  Formation of soluble amyloid oligomers and amyloid fibrils by the multifunctional protein vitronectin.

Authors:  Thuzar M Shin; J Mario Isas; Chia-Ling Hsieh; Rakez Kayed; Charles G Glabe; Ralf Langen; Jeannie Chen
Journal:  Mol Neurodegener       Date:  2008-10-21       Impact factor: 14.195

10.  Transient limb ischemia alters serum protein expression in healthy volunteers: complement C3 and vitronectin may be involved in organ protection induced by remote ischemic preconditioning.

Authors:  Ting Pang; Yang Zhao; Nan-Rong Zhang; San-Qing Jin; San-Qiang Pan
Journal:  Oxid Med Cell Longev       Date:  2013-12-02       Impact factor: 6.543

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.